首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 93 毫秒
1.
陈建光 《河南医学研究》2020,29(21):3887-3889
目的研究椎旁肌间隙入路伤椎置钉技术短节段固定治疗无神经损伤胸腰椎骨折的临床效果。方法选取2016年2月至2018年6月南阳市第一人民医院收治的82例无神经损伤胸腰椎骨折患者,根据手术入路分为对照组和研究组,各41例,对照组行后正中入路伤椎置钉短节段固定,研究组行Wiltse肌间隙入路伤椎置钉技术短节段固定,对比两组手术时间、术中出血量、术后疼痛程度和腰椎功能、Cobb角(头侧上端锥上缘垂线与尾侧端椎下缘垂线交角)畸形矫正率。结果研究组手术时间短于对照组,术中出血量少于对照组(均P<0.05)。研究组术后3、6个月视觉模拟评分法(VAS)评分低于对照组,日本骨科协会评估治疗(JOA)评分高于对照组,Cobb畸形矫正率高于对照组(均P<0.05)。结论椎旁肌间隙入路伤椎置钉技术短节段固定治疗无神经损伤胸腰椎骨折,可有效缩短手术时间,减少术中出血量,矫正Cobb角畸形,减轻腰椎疼痛,改善腰椎功能。  相似文献   

2.
目的:观察经椎旁肌肌间隙入路伤椎置钉短节段椎弓根螺钉内固定对单节段无神经损伤胸腰椎骨折的治疗效果。方法选取单节段胸腰椎骨折患者13例,采用椎旁肌间隙入路伤椎置钉短节段椎弓根螺钉内固定治疗,观察患者术后伤椎矢状面Cobb角、伤椎椎体前缘高度、疼痛、脊柱功能和并发症发生情况。结果本组患者手术均顺利完成,术后均获1年随访,切口甲级愈合;术后伤椎矢状面Cobb角均较术前明显缩小,手术前后比较差异有统计学意义( P﹤0.05);术后伤椎椎体前缘高度较术前明显增高( P﹤0.05);术后VAS评分及ODI均较术前明显下降( P﹤0.05)。治疗过程中均无感染、内固定松动或断裂等并发症发生。结论经椎旁肌肌间隙入路伤椎置钉短节段椎弓根螺钉内固定能有效纠正单节段胸腰椎骨折伤椎前缘高度,纠正后凸畸形,不良反应少。  相似文献   

3.
鲜文峰 《河南医学研究》2020,29(9):1607-1609
目的研究无神经损伤胸腰椎骨折患者接受椎旁肌间隙入路伤椎置钉短节段固定治疗的临床效果。方法选取2016年2月至2017年12月南阳市第二人民医院收治的74例无神经损伤胸腰椎骨折患者,按照手术方案分为对照组和观察组,每组37例。对照组接受传统胸腰椎后侧正中切口入路跨伤椎置钉技术治疗,观察组接受椎旁肌间隙入路伤椎置钉技术短节段固定治疗。对两组患者手术情况、术后恢复情况、手术前后伤椎前缘高度和后凸Cobb指数进行比较。结果观察组患者术中失血量较对照组少,下床活动时间和骨折愈合时间较对照组短,差异有统计学意义(均P<0.05)。术后1周、1 a观察组患者伤椎前缘高度、后凸Cobb指数均优于对照组,差异有统计学意义(均P<0.05)。结论无神经损伤胸腰椎骨折患者接受椎旁肌间隙入路伤椎置钉技术短节段固定治疗可减少术中失血量,加快术后恢复,促进骨折愈合,改善伤椎前缘高度和后凸Cobb角,有较好的临床应用价值。  相似文献   

4.
目的探讨伤椎植骨结合伤椎置钉6钉固定治疗胸腰段骨折的临床疗效。方法回顾分析2009年1月至2011年6月应用伤椎植骨结合伤椎置钉6钉固定治疗胸腰段骨折37例,随访6~28个月,平均13.2个月,观察术后即刻椎体高度恢复、后凸畸形改善情况和末次随访时矫正高度丢失情况、后凸角度丢失、神经功能恢复及内固定情况。结果 26例神经功能损害者末次随访时22例神经功能得到不同程度恢复,4例无变化。术后即刻椎体前缘高度恢复满意,后凸畸形基本矫正。末次随访时未发生内固定断裂,伤椎高度和后凸角丢失轻微。结论伤椎植骨结合伤椎置钉6钉固定固定治疗胸腰段骨折是治疗胸腰段骨折的有效方法。  相似文献   

5.
目的分析经伤椎置钉短节段固定治疗胸腰段脊柱骨折的疗效。方法选取2015年4月至2017年4月我院收治的35例胸腰段脊柱骨折患者作为观察对象,所有患者均采用经伤椎置钉短节段固定治疗,比较治疗前后椎体高度及椎体复位情况。结果术后6个月伤椎前缘高度比明显高于术前,Cobb角明显低于术前,差异具有统计学意义(P0.05)。结论经伤椎置钉短节段固定有利于矫正胸腰段脊柱骨折后凸畸形,强化钉棒系统内固定稳定性,防止术后椎体高度严重丢失现象,安全可靠。  相似文献   

6.
目的:比较经伤椎置钉与跨节段螺钉内固定治疗胸腰椎骨折的临床疗效。方法将68例胸腰椎单节段骨折患者随机分为两组,对照组33例采用传统跨节段4钉内固定法治疗,观察组35例采用经伤椎置6钉内固定法治疗,比较两组手术切口长度、手术时间、术中出血量、脊髓神经损伤Frankel分级改善评分及术后伤椎矫正率、伤椎高度远期丢失率、术后Cobb角矫正值、Cobb角远期丢失值等。结果两组手术切口长度、手术时间、术中出血量、Frankel分级改善评分方面比较差异均无统计学意义( P>0.05);观察组术后Cobb角矫正值、伤椎高度远期丢失率及Cobb角远期丢失值均明显好于对照组( P<0.05)。结论经伤椎置6钉内固定治疗胸腰椎骨折能提供更加坚强牢靠的内固定,减少脊柱后凸畸形矫正率丢失及维持伤椎前柱高度。  相似文献   

7.
目的 观察后路短节段联合伤椎置钉固定治疗胸腰段脊柱骨折的临床效果.结果 选择胸腰段椎体骨折患者54例,采用后路短节段内固定联合伤椎置钉的手术方法进行治疗,对患者术前术后的x线片进行测量,测量其伤椎高度恢复的比例以及后凸角度的纠正情况.结果术前骨折椎体高度(57.5±16.4)%,节段后凸角度(20.7±9.5).;术后骨折椎体高度(93.5±11.5)%,节段后凸角度(5.9±7.4)°.手术前后骨折椎体高度和节段后凸角度差异均有统计学意义(均P<0.01).结论 有条件地应用伤椎置钉技术有利于后路术中复位以及纠正后凸畸形,并且增加内固定系统的强度.  相似文献   

8.
目的:评价经 Wiltse肌间隙入路短节段椎弓根钉结合伤椎椎体成形术治疗胸腰段脊柱爆裂骨折的临床疗效。方法选择32例单节段胸腰段脊柱爆裂骨折患者经 Wiltse 肌间隙入路短节段椎弓根钉固定结合伤椎椎体成形术治疗,随访观察患者术前、术后、末次随访时伤椎前、后缘高度、脊柱后凸 Cobb 角、疼痛视觉模拟评分(VAS),术后 Beaujon-Lassale 功能评分。结果术后1周伤椎前、后缘高度,脊柱后凸 Cobb 角均较术前有显著改善(P <0.05),术后1周患者 VAS 评分较术前明显降低(P <0.05)。末次随访 Beaujon-Lassale 功能评分为(19.4±2.6)分。随访期间2例患者出现腰背部疼痛症状,术后1个月症状完全恢复;2例椎管内渗漏发生,3例术中发生骨水泥椎旁渗漏,但患者均未出现神经症状。结论经 Wiltse 肌间隙入路短节段椎弓根钉固定结合伤椎 PVP 是治疗胸腰段脊柱爆裂骨折的有效方法之一,具有创伤小、出血量少、并发腰痛少等优点。  相似文献   

9.
韩红福 《当代医学》2016,(18):73-74
目的:比较椎旁肌间隙入路微创手术与传统后正中入路手术治疗脊柱胸腰段骨折的疗效差异。方法回顾分析80例无神经症状无须减压的胸腰椎骨折患者,按照手术方式不同分为2组,即经椎旁肌间隙入路微创手术治疗的椎旁肌组(43例)和经传统后正中入路手术治疗的传统组(37例)。比较2组的手术时间、术中出血量、Cobb角矫正率、术后引流率、术后腰背部疼痛VAS等指标。结果椎旁肌组的手术时间(75.3±17.9)min、术中出血量(13.9±40.6)mL及术后引流量(84.6±24.8)mL显著少于传统组[(92.8±14.9)min、(231.3±35.3)mL、(160.4±44.5)mL](P<0.05)。椎旁肌组的术后2、3周的疼痛VAS评分[(2.8±0.4)、(1.1±0.3)]显著低于传统组[(4.3±0.7)、(2.9±0.7)](P<0.05)。2组的术后Coob角矫正率及椎弓根螺钉置入准确率比较,差异无统计学意义。结论椎旁肌间隙入路微创手术法治疗脊柱胸腰段骨折较传统后正中入路手术法,具有操作更简单、创伤更小、出血量更少、更易恢复等优点,值得临床上进一步推广使用。  相似文献   

10.
后路短节段固定联合伤椎置钉在胸腰段脊柱骨折中的应用   总被引:3,自引:0,他引:3  
目的 观察后路短节段内固定联合伤椎置钉在胸腰段脊柱骨折中应用的短期疗效.方法 对27例胸腰段椎体骨折患者采用后路短节段内固定联合伤椎置钉的手术方法进行治疗,对患者术前术后的X线片进行测量,测量其伤椎高度恢复的比例以及后凸角度的纠正情况.结果 术前骨折椎体高度(57.6±16.5)%,节段后凸角度(20.8±9.4)°;术后骨折椎体高度(93.8±11.9)%,节段后凸角度(5.9±7.4)°.手术前后骨折椎体高度和节段后凸角度差异均有统计学意义(均P<0.001).结论 有条件地应用伤椎置钉技术有利于后路术中复位以及纠正后凸畸形,并且增加了内固定系统的强度.  相似文献   

11.
FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…  相似文献   

12.
Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.  相似文献   

13.
In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.  相似文献   

14.
Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.  相似文献   

15.
16.
目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P<0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P<0.05),PaCO2均随观察时间的延长而降低(P<0.05).观察组治疗有效率为87.5%,显著高于对照组的70.0% (P <0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P<0.05),且观察组明显低于对照组(P<0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.  相似文献   

17.
Evidence obtained from randomized controlled trials (RCTs) has been generally accepted as the gold standard in the evaluation of clinical effectiveness. Readers need to understand the trial design, implementation, results, analysis and interpretation, so as to fully Jnderstand the results of RCTs. Thus, the investigators of RCTs have to report these items in a complete, accurate and clear manner. Since 1998, we have conducted several evaluations on the reporting quality of RCTs published in Chinese journals on traditional Chinese medicine (TCM) and results have shown that there is an urgent need for higher quality RCTs on TCM.  相似文献   

18.
Ankylosing spondylitis is a chronic and progressive disorder with inflammation mainly involving the central axis joints. It mainly affects the cervical spine and the lumbosacral area, with the pathogenesis closely related to the kidney and the Governor Vessel (GV). TCM holds that the syndrome is deficiency in origin and excess in superficiality, which is due to insufficiency of the kidney, deficiency of GV, and blocking of the channels with the invasion of exogenous evil, leading to poor circulation of qi and blood and malnutrition of the bones, muscles and joints. The TCM method of tonifying the kidney and strengthening GV to regulate circulation of qi and blood and check the arthralgia pain should be adopted, with the Kidney-Tonifying and GV Strengthening Decoction (益肾强督汤) prescribed.  相似文献   

19.
20.
CHEMOTHERAPY playsa greatrolein the treat- ment of malignanttumors,especiallyingynecolo- gicalones.But inanticancerchemotherapy,leuko-cytopeniaisfrequentlytheprimarydose-limitingsideeffect factor.Moreover,cancersarefrequentlychemoresistantbe-causeof overexpressionof P-glycoprotein(P-gp), which isencodedby multidrugresistancegene (MDR1 ) and detectableinup to50% ofhuman cancersand renderscellsresistancetoanticancerdrugs.The safetyand potentialtherapeuticbenefitof mdr1 gene transferredto h…  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号